vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and System1, Inc. (SST). Click either name above to swap in a different company.

System1, Inc. is the larger business by last-quarter revenue ($51.9M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -26.0%, a 21.2% gap on every dollar of revenue. On growth, System1, Inc. posted the faster year-over-year revenue change (-31.3% vs -47.3%). Over the past eight quarters, IRONWOOD PHARMACEUTICALS INC's revenue compounded faster (-20.2% CAGR vs -21.8%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

System1 is an American Internet advertising company. Formerly known as OpenMail, it was founded in 2013. It describes itself as operating a "Responsive Acquisition Marketing Platform", and cites privacy as one of its principal foci, although it has been criticized for its influence on privacy-focused properties, including search engine Startpage.com. It is headquartered in Marina del Rey, California.

IRWD vs SST — Head-to-Head

Bigger by revenue
SST
SST
1.1× larger
SST
$51.9M
$47.7M
IRWD
Growing faster (revenue YoY)
SST
SST
+16.0% gap
SST
-31.3%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
21.2% more per $
IRWD
-4.8%
-26.0%
SST
Faster 2-yr revenue CAGR
IRWD
IRWD
Annualised
IRWD
-20.2%
-21.8%
SST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
SST
SST
Revenue
$47.7M
$51.9M
Net Profit
$-2.3M
$-13.5M
Gross Margin
41.0%
Operating Margin
14.3%
-33.6%
Net Margin
-4.8%
-26.0%
Revenue YoY
-47.3%
-31.3%
Net Profit YoY
-200.9%
4.8%
EPS (diluted)
$0.01
$-3.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
SST
SST
Q4 25
$47.7M
$51.9M
Q3 25
$122.1M
$61.6M
Q2 25
$85.2M
$78.1M
Q1 25
$41.1M
$74.5M
Q4 24
$90.5M
$75.6M
Q3 24
$91.6M
$88.8M
Q2 24
$94.4M
$94.6M
Q1 24
$74.9M
$84.9M
Net Profit
IRWD
IRWD
SST
SST
Q4 25
$-2.3M
$-13.5M
Q3 25
$40.1M
$-18.5M
Q2 25
$23.6M
$-17.5M
Q1 25
$-37.4M
$-15.9M
Q4 24
$2.3M
$-14.2M
Q3 24
$3.6M
$-23.6M
Q2 24
$-860.0K
$-26.4M
Q1 24
$-4.2M
$-10.5M
Gross Margin
IRWD
IRWD
SST
SST
Q4 25
41.0%
Q3 25
36.9%
Q2 25
35.7%
Q1 25
38.2%
Q4 24
42.1%
Q3 24
28.0%
Q2 24
27.6%
Q1 24
21.9%
Operating Margin
IRWD
IRWD
SST
SST
Q4 25
14.3%
-33.6%
Q3 25
61.8%
-25.3%
Q2 25
53.2%
-20.4%
Q1 25
-70.7%
-17.6%
Q4 24
34.8%
-15.7%
Q3 24
28.0%
-24.6%
Q2 24
26.5%
-30.8%
Q1 24
14.7%
-30.4%
Net Margin
IRWD
IRWD
SST
SST
Q4 25
-4.8%
-26.0%
Q3 25
32.8%
-30.1%
Q2 25
27.7%
-22.4%
Q1 25
-90.9%
-21.3%
Q4 24
2.5%
-18.7%
Q3 24
4.0%
-26.6%
Q2 24
-0.9%
-27.9%
Q1 24
-5.6%
-12.4%
EPS (diluted)
IRWD
IRWD
SST
SST
Q4 25
$0.01
$-3.58
Q3 25
$0.23
$-2.30
Q2 25
$0.14
$-2.23
Q1 25
$-0.23
$-0.21
Q4 24
$0.03
$-3.41
Q3 24
$0.02
$-3.37
Q2 24
$-0.01
$-3.80
Q1 24
$-0.03
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
SST
SST
Cash + ST InvestmentsLiquidity on hand
$215.5M
$86.9M
Total DebtLower is stronger
$305.1M
Stockholders' EquityBook value
$-261.8M
$30.5M
Total Assets
$396.9M
$405.0M
Debt / EquityLower = less leverage
10.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
SST
SST
Q4 25
$215.5M
$86.9M
Q3 25
$140.4M
$54.6M
Q2 25
$92.9M
$63.6M
Q1 25
$108.5M
$43.9M
Q4 24
$88.6M
$63.6M
Q3 24
$88.2M
$69.1M
Q2 24
$105.5M
$75.7M
Q1 24
$121.5M
$69.9M
Total Debt
IRWD
IRWD
SST
SST
Q4 25
$305.1M
Q3 25
$199.5M
$259.2M
Q2 25
$199.3M
$263.3M
Q1 25
$199.2M
$267.4M
Q4 24
$199.0M
$255.1M
Q3 24
$198.8M
$259.2M
Q2 24
$198.6M
$263.3M
Q1 24
$398.3M
$268.6M
Stockholders' Equity
IRWD
IRWD
SST
SST
Q4 25
$-261.8M
$30.5M
Q3 25
$-264.2M
$42.7M
Q2 25
$-308.2M
$58.2M
Q1 25
$-334.1M
$67.2M
Q4 24
$-301.3M
$80.3M
Q3 24
$-311.3M
$90.3M
Q2 24
$-321.7M
$109.4M
Q1 24
$-330.5M
$131.7M
Total Assets
IRWD
IRWD
SST
SST
Q4 25
$396.9M
$405.0M
Q3 25
$396.1M
$385.2M
Q2 25
$342.9M
$429.2M
Q1 25
$327.2M
$419.2M
Q4 24
$350.9M
$459.1M
Q3 24
$389.5M
$479.3M
Q2 24
$395.6M
$511.3M
Q1 24
$438.8M
$521.1M
Debt / Equity
IRWD
IRWD
SST
SST
Q4 25
10.01×
Q3 25
6.07×
Q2 25
4.53×
Q1 25
3.98×
Q4 24
3.18×
Q3 24
2.87×
Q2 24
2.41×
Q1 24
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
SST
SST
Operating Cash FlowLast quarter
$74.6M
$-10.6M
Free Cash FlowOCF − Capex
$74.6M
FCF MarginFCF / Revenue
156.3%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
SST
SST
Q4 25
$74.6M
$-10.6M
Q3 25
$47.6M
$-2.1M
Q2 25
$-15.1M
$24.5M
Q1 25
$20.0M
$-15.9M
Q4 24
$15.2M
$772.0K
Q3 24
$9.9M
$-5.0K
Q2 24
$33.5M
$10.0M
Q1 24
$45.0M
$-16.0M
Free Cash Flow
IRWD
IRWD
SST
SST
Q4 25
$74.6M
Q3 25
$47.6M
Q2 25
$-15.1M
Q1 25
$19.9M
$-16.0M
Q4 24
Q3 24
$9.9M
$-36.0K
Q2 24
$33.4M
Q1 24
$44.9M
FCF Margin
IRWD
IRWD
SST
SST
Q4 25
156.3%
Q3 25
39.0%
Q2 25
-17.7%
Q1 25
48.4%
-21.5%
Q4 24
Q3 24
10.8%
-0.0%
Q2 24
35.4%
Q1 24
60.0%
Capex Intensity
IRWD
IRWD
SST
SST
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.0%
Q1 25
0.1%
0.1%
Q4 24
0.0%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.1%
0.0%
Q1 24
0.1%
0.0%
Cash Conversion
IRWD
IRWD
SST
SST
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons